These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 8143100)

  • 41. Monotherapy versus beta-lactam-aminoglycoside combination treatment for gram-negative bacteremia: a prospective, observational study.
    Leibovici L; Paul M; Poznanski O; Drucker M; Samra Z; Konigsberger H; Pitlik SD
    Antimicrob Agents Chemother; 1997 May; 41(5):1127-33. PubMed ID: 9145881
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Clinical experiences of bacteremia caused by metallo-beta-lactamase-producing gram-negative organisms.
    Lee NY; Yan JJ; Lee HC; Liu KH; Huang ST; Ko WC
    J Microbiol Immunol Infect; 2004 Dec; 37(6):343-9. PubMed ID: 15599466
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Colonization status and appropriate antibiotic therapy for nosocomial bacteremia caused by antibiotic-resistant gram-negative bacteria in an intensive care unit.
    Blot S; Depuydt P; Vogelaers D; Decruyenaere J; De Waele J; Hoste E; Peleman R; Claeys G; Verschraegen G; Colardyn F; Vandewoude K
    Infect Control Hosp Epidemiol; 2005 Jun; 26(6):575-9. PubMed ID: 16018434
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A prospective study of Gram-negative bacteremia in children.
    Levy I; Leibovici L; Drucker M; Samra Z; Konisberger H; Ashkenazi S
    Pediatr Infect Dis J; 1996 Feb; 15(2):117-22. PubMed ID: 8822283
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Current time-to-positivity of blood cultures in febrile neutropenia: a tool to be used in stewardship de-escalation strategies.
    Puerta-Alcalde P; Cardozo C; Suárez-Lledó M; Rodríguez-Núñez O; Morata L; Fehér C; Marco F; Del Río A; Martínez JA; Mensa J; Rovira M; Esteve J; Soriano A; Garcia-Vidal C
    Clin Microbiol Infect; 2019 Apr; 25(4):447-453. PubMed ID: 30096417
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Resistance to newer beta-lactams and related ESBL types in gram-negative nosocomial isolates in Turkish hospitals: results of the multicentre HITIT study].
    Gür D; Gülay Z; Akan OA; Aktaş Z; Kayacan CB; Cakici O; Eraç B; Gültekin M; Oğünç D; Söyletir G; Unal N; Uysal S
    Mikrobiyol Bul; 2008 Oct; 42(4):537-44. PubMed ID: 19149074
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cephalosporin therapeutics for intensive care infections.
    Salacata A; Chow JW
    New Horiz; 1993 May; 1(2):181-6. PubMed ID: 7922401
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Clinical characteristics and outcomes of Pseudomonas aeruginosa bacteremia in febrile neutropenic children and adolescents with the impact of antibiotic resistance: a retrospective study.
    Kim HS; Park BK; Kim SK; Han SB; Lee JW; Lee DG; Chung NG; Cho B; Jeong DC; Kang JH
    BMC Infect Dis; 2017 Jul; 17(1):500. PubMed ID: 28716109
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Bacteriologic profile and antibiogram of blood culture isolates from a children's hospital in Kabul.
    Tariq TM
    J Coll Physicians Surg Pak; 2014 Jun; 24(6):396-399. PubMed ID: 24953929
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Bacteremia with granulocytopenia--microbiology and empiric antibiotic treatment].
    Hammerstrøm J; Jacobsen T
    Tidsskr Nor Laegeforen; 1998 Nov; 118(28):4370-5. PubMed ID: 9889610
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Prevention and treatment of febrile neutropenia].
    Montemurro F; Gallicchio M; Aglietta M
    Tumori; 1997; 83(2 Suppl):S15-9. PubMed ID: 9235724
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Microbiological profiles of pathogens causing nosocomial bacteremia in 2011, 2013 and 2016].
    Wang X; Zhao C; Li H; Chen H; Jin L; Wang Z; Liao K; Zeng J; Xu X; Jin Y; Su D; Liu W; Hu Z; Cao B; Chu Y; Zhang R; Luo Y; Hu B; Wang H
    Sheng Wu Gong Cheng Xue Bao; 2018 Aug; 34(8):1205-1217. PubMed ID: 30152206
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Antibiotherapy in the patient with granulocytopenic cancer].
    Van Der Auwera P; Meunier F
    Pathol Biol (Paris); 1990 Apr; 38(4):302-6. PubMed ID: 2198526
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Bacteremia in childhood cancer.
    Celkan T; Ozkan A; Apak H; Diren S; Can G; Yuksel L; Yildiz I
    J Trop Pediatr; 2002 Dec; 48(6):373-7. PubMed ID: 12521283
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Infection prevention during profound granulocytopenia. New approaches to alimentary canal microbial suppression.
    Schimpff SC
    Ann Intern Med; 1980 Aug; 93(2):358-61. PubMed ID: 7406385
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cefiderocol: A Siderophore Cephalosporin with Activity Against Carbapenem-Resistant and Multidrug-Resistant Gram-Negative Bacilli.
    Zhanel GG; Golden AR; Zelenitsky S; Wiebe K; Lawrence CK; Adam HJ; Idowu T; Domalaon R; Schweizer F; Zhanel MA; Lagacé-Wiens PRS; Walkty AJ; Noreddin A; Lynch Iii JP; Karlowsky JA
    Drugs; 2019 Feb; 79(3):271-289. PubMed ID: 30712199
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Predominance of Gram-negative bacilli and increasing antimicrobial resistance in nosocomial bloodstream infections at a university hospital in southern Taiwan, 1996-2003.
    Wu CJ; Lee HC; Lee NY; Shih HI; Ko NY; Wang LR; Ko WC
    J Microbiol Immunol Infect; 2006 Apr; 39(2):135-43. PubMed ID: 16604246
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Impact of combination antimicrobial therapy on mortality risk for critically ill patients with carbapenem-resistant bacteremia.
    Bass SN; Bauer SR; Neuner EA; Lam SW
    Antimicrob Agents Chemother; 2015 Jul; 59(7):3748-53. PubMed ID: 25845872
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Community-acquired bacteremia in human immunodeficiency virus-infected children in Harare, Zimbabwe.
    Nathoo KJ; Chigonde S; Nhembe M; Ali MH; Mason PR
    Pediatr Infect Dis J; 1996 Dec; 15(12):1092-7. PubMed ID: 8970218
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Risk factors and outcomes for the acquisition of carbapenem-resistant Gram-negative bacillus bacteremia: A retrospective propensity-matched case control study.
    Ting SW; Lee CH; Liu JW
    J Microbiol Immunol Infect; 2018 Oct; 51(5):621-628. PubMed ID: 28732563
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.